Literature DB >> 30907099

[Successful treatment of facial angiofibromas with local sirolimus in childhood in Bourneville-Pringle disease].

Krisztina Bottyán1, Lajos Kemény1,2, Zsanett Renáta Csoma1.   

Abstract

Facial angiofibroma is the characteristic symptom and also a major diagnostic criterion for Bourneville-Pringle disease. The centrofacially localized hamartomatous tumours start to appear in early childhood, and progress over time. Facial angiofibromas represent a significant cosmetological problem for the patients and a therapeutic challenge for the physician. Beside the traditional invasive treating methods, topical sirolimus is a new, promising and well-tolerated treatment modality. Several studies and case reports have been published on this new therapeutic approach, but recommendation for the optimal sirolimus concentration still does not exist. We report here two cases when children were successfully treated with topical sirolimus. Orv Hetil. 2019; 160(13): 516-520.

Entities:  

Keywords:  Bourneville–Pringle disease; Bourneville–Pringle-kór; adenoma sebaceum; angiofibroma; mTOR; sirolimus; szirolimusz

Mesh:

Substances:

Year:  2019        PMID: 30907099     DOI: 10.1556/650.2019.31244

Source DB:  PubMed          Journal:  Orv Hetil        ISSN: 0030-6002            Impact factor:   0.540


  1 in total

1.  Decreased Expression of ZNF554 in Gliomas is Associated with the Activation of Tumor Pathways and Shorter Patient Survival.

Authors:  Andrea Balogh; Lilla Reiniger; Szabolcs Hetey; Peter Kiraly; Eszter Toth; Katalin Karaszi; Kata Juhasz; Zsolt Gelencser; Agnes Zvara; Andras Szilagyi; Laszlo G Puskas; Janos Matko; Zoltan Papp; Ilona Kovalszky; Csaba Juhasz; Nandor Gabor Than
Journal:  Int J Mol Sci       Date:  2020-08-11       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.